Venture-Backed Startups

1 investor

0 investors

Cambrian Protocol is an AI-powered job matching platform built on web3 that connects job seekers and service providers through decentralized smart contracts. The platform uses large language models and vector databases to match candidates with opportunities while enabling transactions via cryptocurrency on Arbitrum and Ceramic.

1 investor

Cambrian Works builds networking and connectivity infrastructure for satellite communications and space operations, including the GigRouter, a space-ready router and edge-computing device with onboard AI/ML processing. Its products support autonomous data management across hybrid space networks and link systems on Earth and in orbit.

1 investor

Cambrian builds vision-to-action AI for industrial robots, using off-the-shelf industrial cameras and standard grippers to enable robot arms to perform high-precision manufacturing tasks. Its models are trained on synthetic data and deliver sub-millimeter precision across varying lighting conditions and part types, including transparent, reflective, and black components.

1 investor

Cambridge Nucleomics develops a single-molecule RNA counting "nanoarray" assay based on solid-state nanopore and DNA nanotechnology for diagnostic testing. The company applies its technology to RNA biology and microbiology-based diagnostics.

1 investor

Cambridge Blockchain is a student-run society at the University of Cambridge that organizes education, research, and development activities in the blockchain space. The organization runs courses, workshops, hackathons, and startup incubation programs to foster a blockchain ecosystem.

2 investors

0 investors

3 investors

CCG.ai develops software that uses clinical and genomic data to help oncologists select appropriate cancer treatments for individual patients, with a focus on identifying predictive biomarkers linked to treatment response.

4 investors

0 investors

Cambridge Crossing (CX) is a mixed-use community development offering spaces to connect, explore, and relax.

1 investor

CDT is a research and innovation centre focused on the conception, development, and testing of advanced materials, with applications spanning electronics, communications, green energy, and life sciences. It operates as the European Research and Innovation Centre of Sumitomo Chemical.

1 investor

Cambridge Education Group provides academic services for universities and students, including university pathway programmes, online and blended course delivery, and campus management, recruitment, and admissions support. Founded in 1952, it partners with UK and European institutions to deliver undergraduate, master's, and medical education programmes.

1 investor

1 investor

The company develops a 6-base sequencing platform (duet evoC) that simultaneously profiles methylation (5mC, 5hmC), genetic variants, and fragmentomics from a single cfDNA sample. Its multi-modal liquid biopsy technology is aimed at biomarker discovery and cancer detection for genomics and life sciences research.

1 investor

0 investors

Cambridge GaN Devices (CGD) designs ICeGaN gallium nitride power transistors that integrate temperature control and gate reliability features and can be driven by standard silicon gate drivers. The devices target power electronics applications such as automotive/EV inverters, offering higher switching frequency, lower losses, and improved energy efficiency versus silicon.

4 investors

0 investors

0 investors

0 investors

Cambridge Mobile Telematics (CMT) builds telematics technology used to measure driving and improve road safety, serving the auto insurance, mobility, and transportation sectors. Its technology is used by millions of drivers and aims to make roads and drivers safer.

3 investors

Cambridge Nutraceuticals develops health supplements based on scientific research, aimed at supporting longer and healthier lives. The company operates in the nutraceuticals and consumer wellness space.

2 investors

Cambridge Orthopaedic Labs develops and patents non-invasive external fixation technology for fracture management, its flagship being the PolyArmour device, which received FDA clearance. It serves orthopaedic clinicians and trauma-surgery patients with alternatives that reduce the need for invasive surgery.

1 investor